Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Amortization of Deferred Charges: 2013-2019

Historic Amortization of Deferred Charges for Veracyte (VCYT) over the last 5 years, with Jun 2019 value amounting to $75,000.

  • Veracyte's Amortization of Deferred Charges rose 837.50% to $75,000 in Q2 2019 from the same period last year, while for Jun 2019 it was $99,000, marking a year-over-year decrease of 77.24%. This contributed to the annual value of $83,000 for FY2019, which is 159.38% up from last year.
  • Latest data reveals that Veracyte reported Amortization of Deferred Charges of $75,000 as of Q2 2019, which was up 837.50% from $8,000 recorded in Q1 2019.
  • In the past 5 years, Veracyte's Amortization of Deferred Charges registered a high of $393,000 during Q4 2017, and its lowest value of $8,000 during Q1 2018.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $17,000 (2017), whereas its average is $58,700.
  • As far as peak fluctuations go, Veracyte's Amortization of Deferred Charges surged by 1,654.55% in 2016, and later slumped by 97.96% in 2018.
  • Over the past 5 years, Veracyte's Amortization of Deferred Charges (Quarterly) stood at $12,000 in 2015, then spiked by 1,654.55% to $193,000 in 2016, then slumped by 86.53% to $393,000 in 2017, then slumped by 97.96% to $8,000 in 2018, then soared by 837.50% to $75,000 in 2019.
  • Its Amortization of Deferred Charges stands at $75,000 for Q2 2019, versus $8,000 for Q1 2019 and $8,000 for Q4 2018.